Valuation (62%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 2.41 | -7.24 |
| PEG Ratio (TTM) | 0.21 | -0.03 |
| P/S Ratio (TTM) | 1.40 | 2.11 |
| P/B Ratio (TTM) | 0.89 | 1.58 |
| P/FCF Ratio (TTM) | -9.76 | 10.82 |
| Price to 5YR AVG Earnings Ratio | 5.75 | 4.75 |
| Price to 5YR AVG FCF Ratio | -46.10 | 8.64 |
Profitability (95%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 21.49% | 6.26% |
| ROE (TTM) | 42.25% | 9.30% |
| Net Profit Margin (TTM) | 57.35% | 16.53% |
| ROIC 5YR AVG | 27.80% | 13.22% |
Growth (97%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 18.30% | 13,283.19% | 8,001.00% |
| Revenue | 6.00% | 41.87% | 44.76% |
| Net Income | 18.23% | 15,642.20% | 9,416.34% |
| Cash Flow | 3.63% | 785.52% | 497.46% |
Health (42%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.46 | 1.72 |
| Quick Ratio (TTM) | 1.41 | 1.56 |
| D/E Ratio (TTM) | 0.64 | 0.67 |
| Interest Coverage (TTM) | 14.26 | 12.92 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.11 | 2.15 |
| LTL to 5YR AVG FCF | -15.89 | 3.21 |
| Shares Outstanding Growth 5YR AVG | 44.81% | 10.84% |